{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:06:01Z","timestamp":1787313961432,"version":"build-2736575974"},"reference-count":47,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T00:00:00Z","timestamp":1671840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Endovascular technologies have significantly improved the outcome of patients with critical limb ischemia (CLI). Drug eluting stents (DES) have documented their efficacy against percutaneous transluminal angioplasty (PTA) and bare metal stents (BMS) in infrapopliteal arterial occlusive disease. However, late in-stent neoatherosclerosis may lead to vascular lumen loss and eventually thrombosis. Polymer free DES constitute a new technology aiming to improve long term patency which their action is still under investigation. The purpose of this study is to report the mechanism of action and to provide a literature review of a novel polymer free amphilimus eluting stent (Cre8, Alvimedica, Instabul, Turkey) in infrapopliteal arterial disease. Methods: Publications listed in electronic databases, European Union Drug Regulating Authorities Clinical Trials Database, as well as scientific programmes of recent interventional vascular conferences were searched. Three studies were included. We analyzed primary and secondary patency, major amputation rate, freedom from CD-TLR, and mortality. Results: Cre8 was implanted in 79 patients with CLI. Most of the patients (n = 65) were Rutherford class 5\u20136 (82.3%), and diabetes mellitus (DM) was present in 66 patients (83.5%). Mean primary patency was 82.5% at 12 months. Mean lesion stented length was 20 mm and 35 mm in two studies. Mean limb salvage was 91.3% at 12 months. Freedom from CD-TLR was reported in two out of the three studies and was 96% and 83.8%. Mortality was 15% and 23.8% in the same studies, whilst it was not reported in one study. Conclusion: Stenting of infrapopliteal arteries with Cre8 is safe and feasible in patients with CLI and diabetes. All studies have shown very good primary patency and freedom from CD-TLR at 12 and 24 months. Larger observational prospective studies and randomized trials are necessary to establish long term effectiveness and clinical outcomes using the non-polymer Cre8 DES.<\/jats:p>","DOI":"10.3390\/medicina59010039","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T04:42:47Z","timestamp":1672116167000},"page":"39","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Polymer Free Amphilimus Drug Eluting Stent for Infrapopliteal Arterial Disease in Patients with Critical Limb Ischemia: A New Device in the Armamentarium"],"prefix":"10.3390","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2183-7160","authenticated-orcid":false,"given":"Konstantinos","family":"Tigkiropoulos","sequence":"first","affiliation":[{"name":"Division of Vascular Surgery, 1st Surgical Department, Faculty of Health Sciences, Aristotle University, Papageorgiou General Hospital, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2202-5359","authenticated-orcid":false,"given":"Manolis","family":"Abatzis-Papadopoulos","sequence":"additional","affiliation":[{"name":"Division of Vascular Surgery, 1st Surgical Department, Faculty of Health Sciences, Aristotle University, Papageorgiou General Hospital, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Sidiropoulou","sequence":"additional","affiliation":[{"name":"Division of Vascular Surgery, 1st Surgical Department, Faculty of Health Sciences, Aristotle University, Papageorgiou General Hospital, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5344-2262","authenticated-orcid":false,"given":"Kyriakos","family":"Stavridis","sequence":"additional","affiliation":[{"name":"Division of Vascular Surgery, 1st Surgical Department, Faculty of Health Sciences, Aristotle University, Papageorgiou General Hospital, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Karamanos","sequence":"additional","affiliation":[{"name":"Division of Vascular Surgery, 1st Surgical Department, Faculty of Health Sciences, Aristotle University, Papageorgiou General Hospital, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Lazaridis","sequence":"additional","affiliation":[{"name":"Division of Vascular Surgery, 1st Surgical Department, Faculty of Health Sciences, Aristotle University, Papageorgiou General Hospital, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Saratzis","sequence":"additional","affiliation":[{"name":"Division of Vascular Surgery, 1st Surgical Department, Faculty of Health Sciences, Aristotle University, Papageorgiou General Hospital, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"j5842","DOI":"10.1136\/bmj.j5842","article-title":"Peripheral artery disease","volume":"360","author":"Morley","year":"2018","journal-title":"BMJ"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"Criqui","year":"2015","journal-title":"Circ. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.avsg.2009.07.034","article-title":"The Impact of Isolated Tibial Disease on Outcomes in the Critical Limb Ischemic Population","volume":"24","author":"Gray","year":"2010","journal-title":"Ann. Vasc. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/eurheartj\/eht288","article-title":"Recent trends in morbidity and in-hospital outcomes of in-patients with peripheral arterial disease: A nationwide population-based analysis","volume":"34","author":"Malyar","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/01.RVI.0000240426.53079.46","article-title":"American Association for Vascular Surgery\/Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC\/AHA Task Force on Practice Guidelines. ACC\/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American Associations for Vascular Surgery\/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC\/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)\u2014Summary of recommendations","volume":"17","author":"Hirsch","year":"2006","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jvir.2015.06.034","article-title":"Long-Term clinical outcomes of infrapopliteal drug-Eluting stent placement for critical limb ischemia in diabetic patients","volume":"26","author":"Spiliopoulos","year":"2015","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1185\/03007990802274379","article-title":"Management of peripheral arterial disease patients: Comparing the ACC\/AHA and TASC-II guidelines","volume":"24","author":"Mohler","year":"2008","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","article-title":"Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia","volume":"58","author":"Conte","year":"2019","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e002376","DOI":"10.1161\/CIRCINTERVENTIONS.114.002376","article-title":"Percutaneous Transluminal Angioplasty and Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI) Trial","volume":"9","author":"Spreen","year":"2016","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1007\/s00330-008-1225-1","article-title":"The evaluation of primary stenting of sirolimus-eluting versus bare-metal stents in the treatment of atherosclerotic lesions of crural arteries","volume":"19","author":"Falkowski","year":"2009","journal-title":"Eur. Radiol."},{"key":"ref_11","first-page":"203","article-title":"Drug eluting stents versus PTA with GP IIb\/IIIa blockade below the knee in patients with current ulcers--The BELOW Study","volume":"51","author":"Tepe","year":"2010","journal-title":"J. Cardiovasc. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.jacc.2012.08.989","article-title":"ACHILLES Investigators. A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial","volume":"60","author":"Scheinert","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2012.04.035","article-title":"Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: Long-term results from a randomized trial","volume":"60","author":"Rastan","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jvs.2011.07.099","article-title":"Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease","volume":"55","author":"Bosiers","year":"2011","journal-title":"J. Vasc. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/CIRCULATIONAHA.113.001811","article-title":"Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): A randomized trial in diabetic patients with critical limb ischemia","volume":"128","author":"Liistro","year":"2013","journal-title":"Circulation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jcin.2013.08.007","article-title":"Drug-eluting stents for revascularization of infrapopliteal arteries: Updated meta-analysis of randomized trials","volume":"6","author":"Fusaro","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1586\/17434440.2014.900434","article-title":"Resolute zotarolimus-eluting coronary stent system for the treatment of coronary artery disease","volume":"11","year":"2014","journal-title":"Expert Rev. Med. Devices"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1586\/17434440.2014.894458","article-title":"The Nobori biolimus-eluting stent: Update of available evidence","volume":"11","author":"Piccolo","year":"2014","journal-title":"Expert Rev. Med. Devices"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa051175","article-title":"Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization","volume":"353","author":"Windecker","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e002943","DOI":"10.1161\/CIRCINTERVENTIONS.115.002943","article-title":"Stent Polymers: Do They Make a Difference?","volume":"9","author":"Rizas","year":"2016","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_22","first-page":"567","article-title":"Polymer coatings and delayed arterial healing following drug-eluting stent implantation","volume":"57","author":"Joner","year":"2009","journal-title":"Minerva Cardioangiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/01.CIR.0000116202.41966.D4","article-title":"Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious?","volume":"109","author":"Virmani","year":"2004","journal-title":"Circulation"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1001\/jama.2012.4111","article-title":"Changes to polymer surface of drug-eluting stents during balloon expansion","volume":"307","author":"DeNardo","year":"2012","journal-title":"JAMA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12928-020-00734-7","article-title":"Mechanisms of drug-eluting stent restenosis","volume":"36","author":"Aoki","year":"2021","journal-title":"Cardiovasc. Interv. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0885328209342000","article-title":"Carbon coatings for cardiovascular applications: Physico-chemical properties and blood compatibility","volume":"25","author":"Fedel","year":"2010","journal-title":"J. Biomater. Appl."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/17434440.2020.1740587","article-title":"The Cre8 Amphilimus-Eluting Stent for the treatment of coronary artery disease: Safety and efficacy profile","volume":"17","author":"Pivato","year":"2020","journal-title":"Expert Rev. Med. Devices"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.15420\/icr.2014.9.3.180","article-title":"Cre8\u2122 Unique Technology in Challenging Daily Practice: Proceedings of a satellite symposium held at EuroPCR on 20\u201323 May 2014 in Paris","volume":"9","author":"Mountfort","year":"2014","journal-title":"Interv. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1152\/physrev.00003.2009","article-title":"Membrane fatty acid transporters as regulators of lipid metabolism: Implications for metabolic disease","volume":"90","author":"Glatz","year":"2010","journal-title":"Physiol. Rev."},{"key":"ref_31","first-page":"421","article-title":"Polymer-free amphilimus-eluting stents in patients with diabetes mellitus","volume":"62","author":"Romaguera","year":"2014","journal-title":"Minerva Cardioangiol."},{"key":"ref_32","first-page":"1087","article-title":"Cre8\u2122 coronary stent: Preclinical in vivo assessment of a new generation polymer-free DES with Amphilimus\u2122 formulation","volume":"7","author":"Moretti","year":"2012","journal-title":"EuroInterv. J. Eur. Collab. Work. Group. Interv. Cardiol. Eur. Soc. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"955211","DOI":"10.3389\/fsurg.2022.955211","article-title":"One-year outcomes following primary stenting of infrapopliteal steno-occlusive arterial disease using a non-polymer sirolimus-eluting stent: Results from a prospective single-centre cohort study","volume":"9","author":"Tigkiropoulos","year":"2022","journal-title":"Front. Surg. Oct."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1016\/j.jvs.2019.08.046","article-title":"LEA 29. Initial experience with cre8 stent for below-knee disease in patients with critical limb ischemia","volume":"70","author":"Santos","year":"2019","journal-title":"J. Vasc. Surg."},{"key":"ref_35","unstructured":"(2022, September 19). Cre8 BTK clinical results in below the knee complex disease. Recorded on-Site at LINC 2022, Leipzig. Marc Sirvent. Available online: http:www.leipzig-interventional-course.com."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijcard.2016.03.088","article-title":"One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry)","volume":"214","author":"Colombo","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"772","DOI":"10.4244\/EIJ-D-18-00148","article-title":"Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients: The RUDI-FREE study","volume":"14","author":"Sardella","year":"2018","journal-title":"EuroIntervention"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jcin.2015.09.020","article-title":"A Randomized Comparison of Reservoir-Based Polymer-Free Amphilimus-Eluting Stents Versus Everolimus-Eluting Stents with Durable Polymer in Patients with Diabetes Mellitus the RESERVOIR Clinical Trial","volume":"9","author":"Romaguera","year":"2016","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.jcin.2021.08.078","article-title":"3-Year Clinical Outcomes After Implantation of Permanent-Polymer Versus Polymer-Free Stent: ReCre8 Landmark Analysis","volume":"14","author":"Voskuil","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ijcard.2014.08.031","article-title":"Randomized comparison between 3-month Cre8 DES vs. 1-month Vision\/Multilink8 BMS neointimal coverage assessed by OCT evaluation: The DEMONSTRATE study","volume":"176","author":"Prati","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/eurheartj\/ehab790","article-title":"Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: The SUGAR trial","volume":"43","author":"Romaguera","year":"2022","journal-title":"Eur. Hear J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jvir.2019.11.015","article-title":"Risk of Death and Amputation with Use of Paclitaxel-Coated Balloons in the Infrapopliteal Arteries for Treatment of Critical Limb Ischemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"31","author":"Katsanos","year":"2020","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_43","first-page":"02320-5","article-title":"A Systematic Review and Meta-Analysis of Sirolimus-Eluting Stents for Treatment of Below-the-Knee Arterial Disease","volume":"S0741\u20135214","author":"Fong","year":"2022","journal-title":"J. Vasc. Surg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/1538574416689429","article-title":"Everolimus-Eluting Stent for Patients with Critical Limb Ischemia and Infrapopliteal Arterial Occlusive Disease","volume":"51","author":"Giaquinta","year":"2017","journal-title":"Vasc. Endovasc. Surg."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jvs.2021.06.019","article-title":"Use of drug-eluting stents in patients with critical limb ischemia and infrapopliteal arterial disease: A real-world single-center experience","volume":"74","author":"AbuRahma","year":"2021","journal-title":"J. Vasc. Surg."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"445","DOI":"10.23736\/S0021-9509.19.10830-0","article-title":"One-year outcome of the everolimus-eluting, balloon-expandable Promus Element and Promus Element Plus stent in the treatment of below-the-knee lesions in CLI patients","volume":"61","author":"Taeymans","year":"2020","journal-title":"J. Cardiovasc. Surg."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.23736\/S0021-9509.16.09546-X","article-title":"Schneinert DOutcome of a drug-eluting stent in longer below-the-knee lesions in patients with critical limb ischemia","volume":"58","author":"Bosiers","year":"2017","journal-title":"J. Cardiovasc. Surg."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/1\/39\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:50:05Z","timestamp":1760147405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/1\/39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,24]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["medicina59010039"],"URL":"https:\/\/doi.org\/10.3390\/medicina59010039","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,24]]}}}